118 related articles for article (PubMed ID: 11753211)
21. [Changes in plasma levels of LPS, TNFalpha and IL-6 in burn patients with severe infection treated with Imipenem or Cefoperazone].
Wang HM; Cao WF; Peng YZ; Xiao GX; Yang XY
Zhonghua Shao Shang Za Zhi; 2004 Apr; 20(2):95-7. PubMed ID: 15312472
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice.
Taylor JM; Ziman ME; Huff JL; Moroski NM; Vajdy M; Solnick JV
Vaccine; 2006 Jun; 24(23):4987-94. PubMed ID: 16621176
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of mouse liver cytochrome P-450 by gram-negative bacteria lipopolysaccharides.
Kaca W; Mara M; Ocenaskova J
Arch Immunol Ther Exp (Warsz); 1996; 44(1):39-44. PubMed ID: 8874768
[TBL] [Abstract][Full Text] [Related]
24. Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms.
Opal SM; Palardy JE; Chen WH; Parejo NA; Bhattacharjee AK; Cross AS
J Infect Dis; 2005 Dec; 192(12):2074-80. PubMed ID: 16288370
[TBL] [Abstract][Full Text] [Related]
25. Biotinylated lipopolysaccharide binds to endotoxin receptor in endothelial and monocytic cells.
Luk JM; Kumar A; Tsang R; Staunton D
Anal Biochem; 1995 Dec; 232(2):217-24. PubMed ID: 8747478
[TBL] [Abstract][Full Text] [Related]
26. Assessment of the ovine acute phase response and hepatic gene expression in response to Escherichia coli endotoxin.
Kabaroff LC; Rodriguez A; Quinton M; Boermans H; Karrow NA
Vet Immunol Immunopathol; 2006 Sep; 113(1-2):113-24. PubMed ID: 16806492
[TBL] [Abstract][Full Text] [Related]
27. Lipopolysaccharide binding protein in the acute phase response of experimental murine Trypanosoma brucei brucei infection.
Ngure RM; Eckersall PD; Mungatana NK; Mburu JN; Jennings FW; Burke J; Murray M
Res Vet Sci; 2009 Jun; 86(3):394-8. PubMed ID: 19022463
[TBL] [Abstract][Full Text] [Related]
28. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.
Artym J; Zimecki M; Kruzel ML
Int Immunopharmacol; 2004 Sep; 4(9):1149-57. PubMed ID: 15251111
[TBL] [Abstract][Full Text] [Related]
29. [The growth and lipopolysaccharide production of Escherichia coli and Pseudomonas aeruginosa].
Weber-Frick C; Schmidt-Lorenz W
Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1988 Aug; 186(5-6):478-93. PubMed ID: 3142165
[TBL] [Abstract][Full Text] [Related]
30. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
[TBL] [Abstract][Full Text] [Related]
31. Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.
Geurtsen J; Banus HA; Gremmer ER; Ferguson H; de la Fonteyne-Blankestijn LJ; Vermeulen JP; Dormans JA; Tommassen J; van der Ley P; Mooi FR; Vandebriel RJ
Clin Vaccine Immunol; 2007 Jul; 14(7):821-9. PubMed ID: 17494641
[TBL] [Abstract][Full Text] [Related]
32. Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria.
Roger T; Glauser MP; Calandra T
J Endotoxin Res; 2001; 7(6):456-60. PubMed ID: 11753217
[TBL] [Abstract][Full Text] [Related]
33. A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro.
Yibin G; Jiang Z; Hong Z; Gengfa L; Liangxi W; Guo W; Yongling L
Biochem Pharmacol; 2005 Jul; 70(2):209-19. PubMed ID: 15935330
[TBL] [Abstract][Full Text] [Related]
34. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
[TBL] [Abstract][Full Text] [Related]
35. [The role of lipopolysaccharide in toxicity of Francisella genus bacteria].
Onoprienko NN; Pavlovich NV
Mol Gen Mikrobiol Virusol; 2003; (3):25-8. PubMed ID: 12966923
[TBL] [Abstract][Full Text] [Related]
36. Role of Toll-like receptor 4 for the pathogenesis of acute lung injury in Gram-negative sepsis.
Baumgarten G; Knuefermann P; Wrigge H; Putensen C; Stapel H; Fink K; Meyer R; Hoeft A; Grohé C
Eur J Anaesthesiol; 2006 Dec; 23(12):1041-8. PubMed ID: 16836770
[TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock.
Hwang YH; Park BK; Lim JH; Kim MS; Park SC; Hwang MH; Yun HI
Eur J Pharmacol; 2007 Feb; 556(1-3):166-71. PubMed ID: 17126323
[TBL] [Abstract][Full Text] [Related]
38. Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia.
Opal SM; Palardy JE; Parejo N; Jasman RL
Crit Care Med; 2003 Mar; 31(3):929-32. PubMed ID: 12627007
[TBL] [Abstract][Full Text] [Related]
39. Lethality in LPS-induced endotoxemia in C3H/HeCr mice is associated with prevalence of proinflammatory cytokines: lack of protective action of lactoferrin.
Zimecki M; Chodaczek G; Kocieba M; Kruzel ML
FEMS Immunol Med Microbiol; 2004 Oct; 42(2):167-72. PubMed ID: 15364100
[TBL] [Abstract][Full Text] [Related]
40. [An antigenic analysis and the protective properties of the R-form lipopolysaccharides of gram-negative bacteria].
Stanislavskiĭ ES; Makarenko TA; Kholodkova EV; Lugowski C
Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):52-6. PubMed ID: 9783402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]